Opko Health Inc (OPK)

$1.50 -0.02 (-1.32%)
Market Cap 1.21B
Revenue (ttm) 713.14M
Net Income (ttm) -53.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7.46%
Debt to Equity Ratio 0.19
Volume 1,227,500
Avg Vol 2,100,158
Day's Range N/A - N/A
Shares Out 793.78M
Stochastic %K 40%
Beta 1.50
Analysts Strong Sell
Price Target $2.65

Company Profile

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 305 575 4100
Address:
4400 Biscayne Boulevard, Miami, United States
tymtested
tymtested Oct. 25 at 12:27 AM
$OPK know this. Companies collaborate and coordinate the timing of quarterly reports with options writers and options expiration dates. The timing for Opko’s Q3 report is perfect. Investors will run the stock up and there will be plenty of time for MM’s to write options and manipulate before the 3rd Friday of nov.
0 · Reply
Mike18181
Mike18181 Oct. 24 at 7:49 PM
$OPK Congrats to you and the board. Congrats on streamlining Bio Reference Labs. EARNING COMING Quaterly.. " we should show the profits from " BRL and royalties. EPS , IMO will be (- 20cents) or -112million loss. IMO or actual will be -96m.. Expenses
0 · Reply
Brasil07
Brasil07 Oct. 24 at 5:45 PM
$OPK 22/23/24/25 Four years and Always the same shit never change until P.F. stay alive it's almost impossible arrive to 2
0 · Reply
Mike18181
Mike18181 Oct. 24 at 12:32 AM
$OPK Stay stoned on Acid and Opko is booming since 2006. The way to hallucinate is add 300 share a qtr to your holdin g and it feels like a gain. Stock Flat buy 300 more the number makes you now feel better. Stock dillution. Buy 600 shares and everything is fine. Tweety bird acid squares will alway cloud your judment and make you feel better. Remember no ROE , take acid and stay numb from the real reality from. FROST
1 · Reply
tymtested
tymtested Oct. 24 at 12:03 AM
$OPK I hope Zack’s is right about increasing Rayaldee revs because the market will be pleasantly surprised!! Rayaldee being solely owned by opko, this will be huge! It is interesting that opko is reporting before Pfizer reports.
0 · Reply
tymtested
tymtested Oct. 23 at 9:46 PM
$OPK Zack's is optimistic about growing revs from Rayaldee!! Look, if Rayaldee happens to take off, OPK is about to move on UP!!
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 6:17 PM
$OPK up 2.8% YTD despite industry slump — what’s driving the stock performance? 📈 ✅ Strong potential in RAYALDEE, the only FDA-approved therapy for specific kidney conditions. 🤝 Strategic partnerships & divestitures to streamline operations and bolster the balance sheet. Find out why OPKO Health is poised for more growth here 👉 https://www.zacks.com/stock/news/2775723/heres-why-you-should-add-opko-health-stock-to-your-portfolio?cid=sm-stocktwits-2-2775723-body-17364&ADID=SYND_STOCKTWITS_TWEET_2_2775723_BODY_17364
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 5:17 PM
$OPK — Undervalued healthcare play with catalysts lining up? 💊 OPKO Health’s RAYALDEE momentum, strategic partnerships, and advancing trials are fueling optimism — even as competition and dependency risks linger. Full investment case here 👉 https://www.zacks.com/stock/news/2775723/heres-why-you-should-add-opko-health-stock-to-your-portfolio?cid=sm-stocktwits-2-2775723-teaser-17355&ADID=SYND_STOCKTWITS_TWEET_2_2775723_TEASER_17355
0 · Reply
tymtested
tymtested Oct. 23 at 4:37 PM
$OPK gettin' ready to SOAR!!
0 · Reply
Barnman09
Barnman09 Oct. 23 at 1:18 PM
$OPK 4Score and Ngenla sales will be up and push the stock price higher.
0 · Reply
Latest News on OPK
OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Oct 22, 2025, 4:05 PM EDT - 2 days ago

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Sep 15, 2025, 8:30 AM EDT - 5 weeks ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

LH

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 9:19 PM EDT - 3 months ago

OPKO Health, Inc. (OPK) Q2 2025 Earnings Call Transcript

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

Jul 31, 2025, 4:05 PM EDT - 3 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

NextPlat Issues Interim CEO Update Shareholder Letter

Jun 30, 2025, 8:01 AM EDT - 4 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

Jun 25, 2025, 11:00 AM EDT - 4 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

OPKO Health to Participate in Two Upcoming Investor Conferences

May 15, 2025, 8:00 AM EDT - 5 months ago

OPKO Health to Participate in Two Upcoming Investor Conferences

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 7:52 PM EDT - 6 months ago

OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

Apr 4, 2025, 8:00 AM EDT - 7 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

OPKO and Entera partner to develop obesity pill

Mar 17, 2025, 8:57 AM EDT - 7 months ago

OPKO and Entera partner to develop obesity pill

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

Mar 11, 2025, 7:00 AM EDT - 8 months ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

LH

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:12 PM EST - 8 months ago

OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

Feb 27, 2025, 4:10 PM EST - 8 months ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 11:45 AM EST - 10 months ago

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

Nov 18, 2024, 8:00 AM EST - 1 year ago

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NXPL

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

Nov 14, 2024, 6:00 AM EST - 1 year ago

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

BABA NXPL

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 8:30 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call Transcript

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

Oct 7, 2024, 8:00 AM EDT - 1 year ago

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

Oct 7, 2024, 8:00 AM EDT - 1 year ago

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

NXPL

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

Sep 16, 2024, 7:30 AM EDT - 1 year ago

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

LH

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

Aug 7, 2024, 4:06 PM EDT - 1 year ago

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

Jul 17, 2024, 4:14 PM EDT - 1 year ago

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 31, 2024, 10:48 AM EDT - 1 year ago

OPKO Health to Participate in the Jefferies Global Healthcare Conference

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:03 PM EDT - 1 year ago

OPKO Health, Inc. (OPK) Q1 2024 Earnings Call Transcript

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

May 3, 2024, 8:00 AM EDT - 1 year ago

OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business

LH

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

Mar 5, 2024, 8:52 AM EST - 1 year ago

AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 8:08 PM EST - 1 year ago

OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

Feb 22, 2024, 4:05 PM EST - 1 year ago

OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

Jan 9, 2024, 4:05 PM EST - 1 year ago

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser's Option to Purchase Additional Notes

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Jan 4, 2024, 11:31 PM EST - 1 year ago

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

Jan 3, 2024, 5:05 PM EST - 1 year ago

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

Nov 28, 2023, 7:00 AM EST - 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

Nov 7, 2023, 6:45 AM EST - 2 years ago

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

SOPH

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 7:32 PM EST - 2 years ago

OPKO Health, Inc. (OPK) Q3 2023 Earnings Call Transcript

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Nov 6, 2023, 4:05 PM EST - 2 years ago

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Nov 2, 2023, 10:00 AM EDT - 2 years ago

New Clinical Data on OPKO Health's RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 31, 2023, 8:00 AM EDT - 2 years ago

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

Oct 25, 2023, 4:25 PM EDT - 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

OPKO Health: FDA Approval To Save The Company

Oct 20, 2023, 1:30 PM EDT - 2 years ago

OPKO Health: FDA Approval To Save The Company

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

Sep 28, 2023, 4:08 PM EDT - 2 years ago

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

Aug 4, 2023, 12:17 AM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q2 2023 Earnings Call Transcript

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

Jul 31, 2023, 2:19 PM EDT - 2 years ago

OPKO Health: Improving Profitability Should Drive Shares Forward Post Q2 Earnings

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

Jul 25, 2023, 4:05 PM EDT - 2 years ago

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

FDA Approves Pfizer's NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

Jun 28, 2023, 6:45 AM EDT - 2 years ago

FDA Approves Pfizer's NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

PFE

OPKO Health's Future After Merck Deal: Bright Or Uncertain

May 11, 2023, 12:29 PM EDT - 2 years ago

OPKO Health's Future After Merck Deal: Bright Or Uncertain

MRK

OPKO Health, Inc. (OPK) Q1 2023 Earnings Call Transcript

May 3, 2023, 8:42 PM EDT - 2 years ago

OPKO Health, Inc. (OPK) Q1 2023 Earnings Call Transcript

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

May 3, 2023, 4:05 PM EDT - 2 years ago

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

tymtested
tymtested Oct. 25 at 12:27 AM
$OPK know this. Companies collaborate and coordinate the timing of quarterly reports with options writers and options expiration dates. The timing for Opko’s Q3 report is perfect. Investors will run the stock up and there will be plenty of time for MM’s to write options and manipulate before the 3rd Friday of nov.
0 · Reply
Mike18181
Mike18181 Oct. 24 at 7:49 PM
$OPK Congrats to you and the board. Congrats on streamlining Bio Reference Labs. EARNING COMING Quaterly.. " we should show the profits from " BRL and royalties. EPS , IMO will be (- 20cents) or -112million loss. IMO or actual will be -96m.. Expenses
0 · Reply
Brasil07
Brasil07 Oct. 24 at 5:45 PM
$OPK 22/23/24/25 Four years and Always the same shit never change until P.F. stay alive it's almost impossible arrive to 2
0 · Reply
Mike18181
Mike18181 Oct. 24 at 12:32 AM
$OPK Stay stoned on Acid and Opko is booming since 2006. The way to hallucinate is add 300 share a qtr to your holdin g and it feels like a gain. Stock Flat buy 300 more the number makes you now feel better. Stock dillution. Buy 600 shares and everything is fine. Tweety bird acid squares will alway cloud your judment and make you feel better. Remember no ROE , take acid and stay numb from the real reality from. FROST
1 · Reply
tymtested
tymtested Oct. 24 at 12:03 AM
$OPK I hope Zack’s is right about increasing Rayaldee revs because the market will be pleasantly surprised!! Rayaldee being solely owned by opko, this will be huge! It is interesting that opko is reporting before Pfizer reports.
0 · Reply
tymtested
tymtested Oct. 23 at 9:46 PM
$OPK Zack's is optimistic about growing revs from Rayaldee!! Look, if Rayaldee happens to take off, OPK is about to move on UP!!
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 6:17 PM
$OPK up 2.8% YTD despite industry slump — what’s driving the stock performance? 📈 ✅ Strong potential in RAYALDEE, the only FDA-approved therapy for specific kidney conditions. 🤝 Strategic partnerships & divestitures to streamline operations and bolster the balance sheet. Find out why OPKO Health is poised for more growth here 👉 https://www.zacks.com/stock/news/2775723/heres-why-you-should-add-opko-health-stock-to-your-portfolio?cid=sm-stocktwits-2-2775723-body-17364&ADID=SYND_STOCKTWITS_TWEET_2_2775723_BODY_17364
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 5:17 PM
$OPK — Undervalued healthcare play with catalysts lining up? 💊 OPKO Health’s RAYALDEE momentum, strategic partnerships, and advancing trials are fueling optimism — even as competition and dependency risks linger. Full investment case here 👉 https://www.zacks.com/stock/news/2775723/heres-why-you-should-add-opko-health-stock-to-your-portfolio?cid=sm-stocktwits-2-2775723-teaser-17355&ADID=SYND_STOCKTWITS_TWEET_2_2775723_TEASER_17355
0 · Reply
tymtested
tymtested Oct. 23 at 4:37 PM
$OPK gettin' ready to SOAR!!
0 · Reply
Barnman09
Barnman09 Oct. 23 at 1:18 PM
$OPK 4Score and Ngenla sales will be up and push the stock price higher.
0 · Reply
tymtested
tymtested Oct. 23 at 12:04 PM
$OPK with the market’s current level of optimism for OPKO, now is a great buying opportunity! Growing revs into Q4 and lab profitability!
0 · Reply
Barnman09
Barnman09 Oct. 23 at 11:52 AM
$OPK Hopefully a great quarter coming! +350 mil.?
0 · Reply
tymtested
tymtested Oct. 22 at 9:10 PM
$OPK October 29 seems early for the quarterly report.. Maybe there's GOOD news!!
2 · Reply
LongAllDay
LongAllDay Oct. 22 at 12:50 AM
$OPK absolute power house blue chip type stock just collect the fat dividend that frost gives you and smile boys
1 · Reply
SmallCapAlert
SmallCapAlert Oct. 21 at 6:25 PM
$LTELF Watchlist: ​$LTELF cheapest german company in defense sector https://www.lstelcom.com/en/company/newsroom/news/article/ls-telcom-receives-significant-orders-from-the-gulf-region-in-the-electronic-warfare-sector/ Revenue: $35 million Marketcap: $22 million FreeFloat: 1.6 million $RTX Marketcap: $233 billion $IONQ Marketcap: $19 billion $TSM Marketcap: $1.5T $OPK Marketcap: $1.2 billion
0 · Reply
LongAllDay
LongAllDay Oct. 20 at 7:35 PM
$OPK holy fricking volume frostman!!!! I just saw a 100 share block get absolutely GOBBLED up
0 · Reply
tymtested
tymtested Oct. 20 at 6:33 PM
$OPK HUGE BUYING OPPORTUNITY! 50 SMA IS ABOUT TO CROSS ABOVE THE 200 SMA AND THE STOCK IS TRADING ABOVE ALL SMA'S!!
0 · Reply
Mike18181
Mike18181 Oct. 20 at 1:02 PM
$OPK Have WGS buyout Opko Get rid of the drugs and losses. WGS with 300m + in revenue can add 600m and grow this way.. Yes... im serious
0 · Reply
sabbahsamuel
sabbahsamuel Oct. 19 at 2:36 PM
Sell-off at Tel Aviv, as the ceasefire breached by the Hamas resumed the fights Indices: TA-35: -1.14% TA-125: -1.30% TA-Construction: -3.60% TA-RealEstate: -2.26% TA-Oil&Gas: -1.67% TA-Banks5: -0.45% TA-Technology: -1.61% Stocks on TASE $TEVA : -2.38% $OPK : -2.21% $ESLT : -2.80%
1 · Reply
Resurrected_Magic
Resurrected_Magic Oct. 19 at 2:31 AM
$OPK claros was a pump and dump scam. It was promoted to ride thr theranos wave then dumped. https://www.fiercebiotech.com/medtech/roche-nabs-fda-clearance-alzheimers-biomarker-blood-test
0 · Reply
therealcryptocowboy
therealcryptocowboy Oct. 19 at 1:14 AM
$OPK cmon fam help me out here!!!!https://c.org/XbNrDf8F6r
0 · Reply
resurrect_momo21
resurrect_momo21 Oct. 16 at 4:52 PM
$COCP $OPK the original 🤡 con biscayne boy toy 😂 @The_Original_Magic 8200 meltdown bash paid posts @Resurrected_Magic 6791 bash free posts former paid basher not one single winner ever 🤡
0 · Reply